华邦健康股价涨5.09%，华宝基金旗下1只基金重仓，持有10.46万股浮盈赚取2.62万元

Core Insights - Huabang Health's stock increased by 5.09% to 5.16 CNY per share, with a trading volume of 365 million CNY and a turnover rate of 3.83%, resulting in a total market capitalization of 10.216 billion CNY [1] Company Overview - Huabang Life Health Co., Ltd. is located at 69 Xingguang Avenue, Renhe, Yubei District, Chongqing, established on March 11, 1992, and listed on June 25, 2004 [1] - The company's main business includes the research, production, and sales of pharmaceutical formulations, raw materials, and pesticides, as well as pharmaceutical distribution and pesticide import/export [1] - Revenue composition: Agricultural new materials 56.82%, pharmaceutical products 27.33%, tourism services 8.29%, others 4.34%, medical services 3.21% [1] Fund Holdings - Huabang Health is a significant holding in Huabao Fund, specifically in the Huabao Quantitative Stock Mixed Initiation A (017715), which held 104,600 shares in the second quarter, accounting for 1.37% of the fund's net value, ranking as the third-largest holding [2] - The fund has achieved a year-to-date return of 28.1%, ranking 3076 out of 8160 in its category, and a one-year return of 30.62%, ranking 2391 out of 8026 [2] Fund Manager Performance - The fund manager Xu Linming has a tenure of 16 years and 28 days, with a total fund asset size of 1.618 billion CNY, achieving a best return of 98.6% and a worst return of -43.03% during his tenure [3] - Co-manager Yu Yinyou has a tenure of 3 years and 111 days, managing assets of 491 million CNY, with a best return of 33.86% and a worst return of -0.92% [3]